AbstractObjectivesThe purpose of this study was to investigate the effects of Angelica gigas Nakai extract(AGNE) and Bacillus polyfermenticus KJS-2 (BP2) on atopic dermatitis (AD) induced by 2, 4-dinitrochlorobenzene (DNCB) in mice.
MethodsIn the experiment, we divided mice into four groups: a control group, a DNCB group, an AGNE group, and an AGNE+BP2 group. Then we examined the changes in scratching frequency, clinical aspects on dorsum skin, immunoglobulin (IgE), cytokines (TNF-α, IL-6) and expression of COX-2.
ResutlsFrom the experiment, the scratching frequency was significantly dropped in AGNE group and AGNE+BP2 group. Clinical observations of dorsum skin, there were a severe keratotic lesion and drop of dead skin cell in DNCB group, but symptoms of AD were decreased 39.6% in AGNE group and 49.6% in AGNE+BP2 group during 3 weeks. IgE, TNF-α and IL-6 were decreased significantly in both AGNE and AGNE+BP2 group. Expression of COX-2 was also decreased significantly in both groups.
참고문헌2. Park YM. Advan ces In the Pathophysiology of Atopic Dermatitis. Pediatr Allergy Respir Dis. 2006; 16:3. 189–96.
3. Cha KB, Kim YS, Seol IC. Literatual study on Atopic dermatitis. J Res Institute Korean Med Daejeon Univ. 2005; 14:2. 113–26.
4. Park MC, Kim JM, Hong CH, Hwang CY. A literature study about the comparison of Oriental-Occidental medicine on the Atopic dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2002; 15:1. 226–52.
5. Gong NM, Jee SY. A Literature Study about comparision of Eastern-Western medicine on the Atopic dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 1999; 12:1. 241–53.
6. Chang IM. Treatise on asian herbal medicines. Seoul National Univ Press Inc. 2003; 1:176–7.
7. An SH, Kim HH. Lonicera Japonica inhibits atopy dermatitis in NC/Nga mouse through regulation of INOS by NF-kB suppression. Korean J Orient Physiol Pathol. 2010; 24:2. 278–83.
8. Lee SI. Phytology. Seoul: Suseowon;1981. p. 101–2.
9. Ahn KS, Sim WS, Kim HM, Han SB, Kim IH. Immunostimulating components from the root of Angelica gigas Nakai. Korean J Pharmacogn. 1996; 27:254–61.
10. Ahn KS, Sim WS, Kim IH. Decursin a cytotoxic agent and protein kinase c activator from the root of angelica gigias. Planta Med. 1995; 62:7–9.
11. Kim CH, Kwon MC, Han JG, Na CS, Kwak HG, Choi GP, et al. Skin-Whitening and UV-Protective Effects of Angelica gigas Nakai Extracts on Ultra High Pressure Extraction Process. Korean J Medicinal Crop Sci. 2008; 16:4. 255–60.
12. Jang SI, Kim HJ, Hwang KM, Pae HO, Yun YG, Chung HT, et al. Anti-Inflammatory Effect of Ethanol Extract of Angelica uchiyamana in Activated Murine RAW 264.7 macrophages. Korean J Orient Med Prescription. 2002; 10:2. 189–97.
13. Kim MY, Kwon OJ, Choo BK, Lee CW, Park EH, Kim HJ. The Effect of Angelicae gigantis radix according to Heat-process on Anti-Oxidant and Anti-Thrombotic. Kor J Herbol. 2016; 31:3. 13–22.
14. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004; 113:5. 651–7.
15. Park MC, Kim JM, Hong CH, Hwang CY. A literature study about the comparison of Oriental-Occidental medicine on the Atopic dermatitis. The Journal of Oriental Medical Surgery, Ophthalmology & Otolaryngology. 2002; 15:1. 226–52.
16. Kim BS. The effect of Bacillus polyfermenticus KJS-2 and Angelica gigias Nakai ethanol extract on hyperlipidemia. Department of Pharmacy Graduate School Kyungsung University;2015.
17. Kang JS, Jun KD, Kim SW, Jo WS, Kwon JY, Moon KH. Antibacterial activities of B. polyfermenticus SCD against pathogenic bacteria and effects on animals and humans. Yakhak hoeji. 2004; 48:1. 70–74.
18. Kim SA, Oh HK, Kim JY, Hong JW, Cho SI. A review of pharmacological effects of Angelica gigas, Angelica sinensis, Angelica acutiloba and their bioactive compounds. J Korean Orient Med. 2011; 32:4. 1–24.
19. Rho SS. Full-color Dermatology. Seoul: IBC design. 2006; 499:512–27.
20. Park JM, Chae JW. Effects of Aurantii Immaturus Fructus(AI) on Atopic Dermatitis (AD) Induced by DNCB in Mice. J Pediatr Korean Med. 2016; 29:1. 27–43.
21. Jung JY, Han KH. Common skin disease in Korea. Seoul: Emdi world;2009. p. 37–48.
22. Gong NM, Jee SY. A Literature study about comparison of Eastern-Western medicine on the Atopic dermatitis. J Orient Med Ophthalmol Otolaryngol Dermatol. 1999; 12:1. 241–53.
23. Jo SY. Hwalyousimseo. Shanghai: Daedongseokgook;1933. p. 2–8.
24. Wang BD. Yookgwajoonseung. Seoul: Seongbosa;1982. p. 85–7.
25. Jo HC. Sungjechonglok Shinmoonnong. 1978; 1439–40.
26. Jang SI, Kim HJ, Hwang KM, Pae HO, Yun YG, Chung HT, et al. Anti-Inflammatory Effect of Ethanol Extract of Angelica uchiyamana in Activated Murin RAW 264,7 macrophages. The Korean Journal of oriental medical prescription. 2002; 10:2. 189–97.
27. Gibson GR, Robertfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995; 125:1401–12.
28. Jo EH, Kim TK, Hong SJ, Jung DY, Hwang SY, Ahn SH. The Case Study of Lactobacillus mixture culture fluid on Atopic dermatitis. J Korean Med. 2015; 36:3. 135–43.
29. Kim KM, Kim MJ, Kim DH, Park YS, Kang JS. Characterization of Bacillus polyfermenticus KJS-2 as a probiotic. J Microbiol Biotechnol. 2009; 19:1013–8.
30. Kim DH, Kang KR, Kim HY, Yoon SY, Kim CG, Tokutaro Y, et al. Structure determination of macrolactin compounds with antibacterial activites isolated from bacillus polyfermenticus KJS-2. J Life Science. 2010; 1792–800.
31. Kim HJ. Relation between atopic dermatitis and residential environment. Master’s thesis. Dept. of Housing & Interior Design of Yonsei Uni.;2005.
32. Yang JM. Genetics of atopic dermatitis. Update in dermatology for a dermatologist. 2003; 6–9.
33. Leung DYM. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol. 2000; 105:860–76.
34. Morren Ma, Przybilla B, Bamelis M, Heykants B, Reynaers A, Degreef H. Atopic dermatitis: triggering factors. J Am Acd Dermatol. 1994; 31:467–73.
35. van Reijsen FC, Bruijinzeel-Koomen CAFM, Kalthoff FS, Maggi E, Romagnani S, Westland JKT, et al. Skin-derived aeroallergen-specific T-cell clones of Th2 Phenotype in patients with atopic dermatitis. J Allergy Clin Immunol. 1992; 90:184–93.
36. Leung DYM, Sorter NA. Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol. 2001; 44:S1–12.
37. Bernnan FM, Maini RN, Feldmann M. Cytokine expression in chronic inflammatory disease. Br Med Bull. 1995; 51:2. 368–84.
38. Baeuerle PA. The inducible transcription activatior NF-κB Regulation by distinct subunits. Biochim Biophys Acta. 1991; 1072:63–70.
39. Golden BD, Abramson SB. Selective coclooxygenase-2 inhibitor. Rheumatic Disease Clinics of North America. 1999; 25:359–78.
41. Park MC, Choi IH. Analysis on the Dermatosurgical Prescriptions in BangYakHapPyun. J Orient Med Ophthalmol Otolaryngol Dermatol. 2003; 16:1. 42–62.
|
|